Alberta Investment Management Corp acquired a new stake in CME Group Inc. (NASDAQ:CME - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 46,100 shares of the financial services provider's stock, valued at approximately $10,180,000.
A number of other institutional investors and hedge funds have also made changes to their positions in the business. Asset Dedication LLC boosted its stake in shares of CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider's stock worth $26,000 after buying an additional 37 shares during the period. Northwestern Mutual Investment Management Company LLC increased its position in CME Group by 0.3% in the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider's stock valued at $3,147,000 after acquiring an additional 37 shares during the period. Rehmann Capital Advisory Group increased its position in CME Group by 4.3% in the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider's stock valued at $243,000 after acquiring an additional 37 shares during the period. Endowment Wealth Management Inc. raised its stake in CME Group by 4.4% during the 4th quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider's stock valued at $244,000 after acquiring an additional 38 shares during the last quarter. Finally, NBT Bank N A NY raised its stake in CME Group by 2.3% during the 1st quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider's stock valued at $492,000 after acquiring an additional 38 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.
CME Group Price Performance
Shares of NASDAQ:CME opened at $269.80 on Monday. The business's 50 day simple moving average is $250.20 and its 200-day simple moving average is $280.19. The firm has a market capitalization of $97.01 billion, a price-to-earnings ratio of 22.88, a price-to-earnings-growth ratio of 3.14 and a beta of 0.23. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 12 month low of $218.31 and a 12 month high of $329.16.
CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.08. The company had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.CME Group's revenue was up .8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.96 earnings per share. As a group, equities analysts forecast that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.
CME Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be paid a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group's dividend payout ratio (DPR) is 44.11%.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on the company. The Goldman Sachs Group lowered their target price on CME Group from $267.00 to $245.00 and set a "sell" rating on the stock in a research note on Tuesday, June 30th. Piper Sandler cut their price target on CME Group from $329.00 to $295.00 and set an "overweight" rating for the company in a research note on Wednesday, July 15th. Keefe, Bruyette & Woods raised CME Group from a "market perform" rating to an "outperform" rating and set a $305.00 price target for the company in a report on Thursday, June 18th. Wall Street Zen lowered shares of CME Group from a "sell" rating to a "strong sell" rating in a research report on Saturday, August 1st. Finally, Barclays lowered their target price on shares of CME Group from $316.00 to $270.00 and set an "equal weight" rating on the stock in a report on Thursday, July 9th. Ten research analysts have rated the stock with a Buy rating, five have given a Hold rating and three have assigned a Sell rating to the company's stock. According to MarketBeat.com, CME Group presently has a consensus rating of "Hold" and an average price target of $291.81.
View Our Latest Stock Report on CME
Insider Activity
In related news, Director William R. Shepard acquired 325 shares of the business's stock in a transaction that occurred on Thursday, June 25th. The stock was purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the transaction, the director directly owned 260,442 shares of the company's stock, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.30% of the stock is owned by corporate insiders.
CME Group Company Profile
(
Free Report)
CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Read More
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
